SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-012700
Filing Date
2021-05-24
Accepted
2021-05-24 16:16:30
Documents
69
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 726584
2 ex31-1.htm EX-31.1 18075
3 ex31-2.htm EX-31.2 19961
4 ex32-1.htm EX-32.1 4207
5 ex32-2.htm EX-32.2 4289
  Complete submission text file 0001493152-21-012700.txt   5132264

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE otlc-20210331.xml EX-101.INS 842626
7 XBRL SCHEMA FILE otlc-20210331.xsd EX-101.SCH 54925
8 XBRL CALCULATION FILE otlc-20210331_cal.xml EX-101.CAL 59287
9 XBRL DEFINITION FILE otlc-20210331_def.xml EX-101.DEF 320936
10 XBRL LABEL FILE otlc-20210331_lab.xml EX-101.LAB 404682
11 XBRL PRESENTATION FILE otlc-20210331_pre.xml EX-101.PRE 382516
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 21955107
SIC: 2834 Pharmaceutical Preparations